CA2160776A1 — Transdermal therapeutic systems for the administration of serotonin agonists
Assigned to LTS Lohmann Therapie Systeme AG · Expires 1994-11-24 · 31y expired
What this patent protects
The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
USPTO Abstract
The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.